Parkinson's Disease Online
Powered by the Michael J. Fox Foundation
Welcome
Guest
|
Be a part of PD Online Research
E-mail address:
*
Password:
*
recover password
Facebook
Twitter
Search the site:
Discussions
LRRK2 Antibodies
Protocol Q&A
News
Papers of the Week
Newsletters
Resources
Genes
Research Models
Clinical Trials
Classifieds
PD Guide
Funding
Funding News
Meetings
Calendar
Meeting Reports
Reporter Awards
Members
Member Directory
Apply for Membership
Ann Graybiel, PhD
Job title:
Institute Professor
Organization:
Massachusetts Institute of Technology
Contributions:
Published Contributions:
ABSTRACT: Evaluation of the Striatum-enriched Genes CalDAG-GEF1 and CalDAG-GEF2 as Targets for the Treatment and Prevention of L-DOPA Induced Dyskinesia
response to:
PD Therapeutics 2009: Poster Abstracts
17 Sep 2009 04:13 PM EST
The most widely prescribed therapy for Parkinson’s disease is levodopa (L-DOPA), which allows patients to regain motor control. However, many patients develop adverse reactions to L-DOPA, ...